Abstract GS5-06: A U.S. food and drug administration pooled analysis of outcomes of older women with hormone-receptor positive metastatic breast cancer treated with a CDK4/6 inhibitor as initial endocrine based therapyHarpreet Singh, Richard Pazdur, Erik Bloomquist et al.|Cancer Research|2018Cited by 15